1-5 of 5
J Cao
Close
Sort by
Journal Articles

Safety and efficacy of an anti–human APC antibody for prophylaxis of congenital factor deficiencies in preclinical models

Miao Jiang, Fei Yang, Yizhi Jiang, Lu Cheng, Jingjing Han, Jiawei Yi, Bin Zuo, Lulu Huang, Zhenni Ma, Tianyi Li, Lijuan J. Cao, Zhisong Xia, Xia Bai, Chenjun Jia, Teddy Tat Chi Yang, Naomi L. Esmon, Changgeng Ruan, Lijun Xia, Charles T. Esmon, Yue Han, Depei Wu, Jun Xu
Journal: Blood
Blood (2023) 142 (12): 1071–1081.
https://doi.org/10.1182/blood.2023020005
Published: 2023
Includes: Supplemental data
Journal Articles

A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL

Lijun Zhao, Shuhong Li, Xiaoyi Wei, Xuexiu Qi, Dong Liu, Lei Liu, Feiqiu Wen, Ji-shuai Zhang, Feng Wang, Ze-lin Liu, Yu J. Cao
Journal: Blood
Blood (2022) 140 (16): 1790–1802.
https://doi.org/10.1182/blood.2022016243
Published: 2022
Includes: Supplemental data
Journal Articles

VH gene usage is multiple myeloma: complete absence of the VH4.21 (VH4- 34) gene

MB Rettig, RA Vescio, J Cao, CH Wu, JC Lee, E Han, M DerDanielian, R Newman, C Hong, AK Lichtenstein, JR Berenson
Journal: Blood
Blood (1996) 87 (7): 2846–2852.
https://doi.org/10.1182/blood.V87.7.2846.bloodjournal8772846
Published: 1996
Journal Articles

Transplantation of CD34+ peripheral blood progenitor cells after high- dose chemotherapy for patients with advanced multiple myeloma

G Schiller, R Vescio, C Freytes, G Spitzer, F Sahebi, M Lee, CH Wu, J Cao, JC Lee, CH Hong
Journal: Blood
Blood (1995) 86 (1): 390–397.
https://doi.org/10.1182/blood.V86.1.390.bloodjournal861390
Published: 1995
Journal Articles

The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma

RA Vescio, CH Hong, J Cao, A Kim, GJ Schiller, AK Lichtenstein, RJ Berenson, JR Berenson
Journal: Blood
Blood (1994) 84 (10): 3283–3290.
https://doi.org/10.1182/blood.V84.10.3283.3283
Published: 1994